Group K Plans to Attend the 2019 AACC Conference

Philadelphia, PA – July 16, 2019– Group K Diagnostics (GKD), a biotechnology innovator aiming to overhaul the diagnostic process for both patient and caregiver, plans to attend the upcoming 71st American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California from August 4-8. The company will use the time at the show to highlight its research developments, network and attend business meetings with industry leaders. To read the entire release, visit here.

Liam Lindsaynewsletter